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Background. Resistance training research has demonstrated positive eﬀects for persons with Parkinson’s disease (PD), but the
numberofacutetrainingvariablesthatcanbemanipulatedmakesitdiﬃculttodeterminetheoptimalresistancetrainingprogram.
Objective. The purpose of this investigation was to examine the eﬀects of an 8-week resistance training intervention on strength
and function in persons with PD. Methods. Eighteen men and women were randomized to training or standard care for the 8-week
intervention. The training group performed 3 sets of 5–8 repetitions of the leg press, leg curl, and calf press twice weekly. Tests
included leg press strength relative to body mass, timed up-and-go, six-minute walk, and Activities-speciﬁc Balance Conﬁdence
questionnaire. Results. There was a signiﬁcant group-by-time eﬀect for maximum leg press strength relative to body mass, with
the training group signiﬁcantly increasing their maximum relative strength (P<. 05). No other signiﬁcant interactions were noted
(P>. 05). Conclusions. Moderate volume, high-load weight training is eﬀective for increasing lower-body strength in persons with
PD.
1.Introduction
IndividualswithParkinson’sdisease(PD)exhibitdeﬁciencies
in the ability of the neuromuscular system to produce
force [1], including both its rate [2–5] and magnitude [4–
9]. Mechanisms are not clearly understood, albeit some
investigators have suggested an inability to fully activate
the motor neuron pool [10]. As a result, strength deﬁcits
appear to be at least partially central in nature, as PD drug
therapy [2, 11] and deep brain stimulation [12]i m p r o v e
neuromuscular performance. Loss of muscle mass may also
be a mechanism by which weakness is caused [13], even
though strength relative to body mass has been shown to be
lower in PD [14]. Irrespective of mechanism, impaired force
production, or muscle weakness, is a common symptom
of PD [15], a secondary cause of bradykinesia [16], and
a contributing factor in postural instability [17]. These
eﬀects, along with the obvious associations with functional
mobility [14] and quality of life, dramatically underscore
the need to develop interventions that ameliorate these
impairments.
Recent reviews of literature stressed the eﬃcacy of
exercise interventions in treating the symptoms for persons
with PD, but questions were posed as to the optimal exercise
prescription[18,19].Falvoetal.[1]highlightedthepotential
beneﬁts of resistance training in particular, but little research
has been done to determine the optimal resistance training
program for persons with PD, particularly in terms of
exercise volume. The resistance training programs utilized
in these few studies to date have varied widely due to the
number of acute training variables such as repetitions per
set, number of sets, mode of weight training, rest periods,2 Parkinson’s Disease
and frequency. However, even with the variation in exercise
programming and testing procedures, resistance training
interventions have been eﬀective in treating the symptoms
of PD [1]; increases in strength [20–22], gait velocity [23],
and functional mobility have been noted [20, 21, 24].
The purpose of this investigation was to examine the
eﬀects of a moderate volume, high-load 8-week resistance
training intervention on lower-body strength and functional
mobility in persons with mild to moderate PD, and to
examine the relationship of strength to neuromuscular
function. Our research is novel in that we structured the
program around a multijoint extensor action (leg press) as
extensor actions are disproportionately aﬀected by PD [25],
and multijoint exercises more closely mimic the activities of
daily living (ADL). Repetition range was considerably lower
(implying greater load) than extant studies. The exercises
wereisoinertial(i.e.,constantgravitationalload),alsosimilar
to the resistance encountered in ADL. We also used a 3-set
per exercise training volume that is proposed to be superior
to one-set programs in older populations [26, 27], but has
not been used in persons with PD.
2. Methods
2.1. Participants. Eighteen participants with mild to mod-
erate PD were randomized to either a training (6 men,
3 women) or standard care control group (5 men, 4
women). All participants provided written informed consent
as approved by the University Institutional Review Board.
All participants were carefully screened to have the ability to
walk a 20-foot path, turn, and return to the start without
use of an assistive device. Subjects were not participating
in a structured exercise program, and were instructed to
maintaintheirnormalactivitiesforthedurationofthestudy.
Participants with orthostatic hypotension, dementia (Mini-
Mental State Examination Scores <24), or other signiﬁcant
comorbidities (i.e., stroke, musculoskeletal problems in the
lower extremity) were not recruited into the study. Inclusion
criteria included primary PD with a Hoehn and Yahr stage of
1–2.5 when in an “on” state of medication. All participants
reported to the lab in their optimally medicated state for
both testing and training (typically within 30min to 2 hours
of their ﬁrst morning dose), and none were receiving deep-
brain stimulation.
2.2.TestingProcedures. Testing included abatteryofstrength
and functional measures. Maximum strength for the lower-
body was assessed using a leg press machine (Hammer
Strength,Figure 1).Themaximumweightlifted,afterwarm-
up, for one repetition was recorded as the one repetition
maximum (1-RM), in accordance with the methods of
Verdijketal.[28].Thisweightwasthendividedbybodymass
to generate a measure of relative strength. We propose this
measure to be a good indicator of tasks that involve moving
one’s ownbody masssuchasrising fromachair[6].Strength
data from the other training exercises were not recorded.
The Activities-speciﬁc Balance Conﬁdence (ABC) scale
was used to evaluate participants’ conﬁdence level of daily
TRN CNTL
Pre
Post
0
1
2
3
4
R
e
l
a
t
i
v
e
s
t
r
e
n
g
t
h
(
k
g
l
i
f
t
e
d
/
k
g
b
o
d
y
m
a
s
s
)
Figure 1: Leg Press 1-RM adjusted for body mass (kg/kg) for
TRN (Pre=4.7±1.4, Post 5.9±1.6) and CNTL (Pre=4.4±1.5,
Post 4.4 ±1.4).Asigniﬁcantinteractioneﬀectwasnoted(P = .001).
Post hoc analysis indicates a signiﬁcant increase over time for TRN
(P = .001).
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Figure 2: TUG (s) for TRN (Pre=5.8±0.50, Post 5.7±0.80)
and CNTL (Pre=7.5±1.18, Post 6.75±1.21). No signiﬁcant
interaction (P = .223) or time eﬀect (P = .069) was noted.
activities [29]. The percentage scores of 16 questions were
summed to yield a single ABC score for data analysis. The
higher the score, the more conﬁdent a participant perceives
theirbalanceabilities.Thisscalehasbeenshowntobeagood
indicator of balance ability and a predictor of fall likelihood
[30, 31]. The ABC scale has been validated in PD [32].
Timed up-and-go was administered as an indicator of
ADL ability [33]. Participants were instructed to rise from
a chair (without using their arms) on a verbal cue, walk three
meters to a cone at a comfortable pace without running, and
return to the chair. The best time from the rise to touch
down for two trials was used for analysis and a harness
system (Solostep) was available if needed to ensure safety of
participants during testing. Functional capacity was assessedParkinson’s Disease 3
using the 6-minute walk test (6MWT). The 6MWT is a
standard test used in clinical settings for measuring the
eﬃcacy of therapeutic interventions [34]. The total distance
(m) was measured as participants walk for a period of six
minutes.
After baseline testing, participants were gender-match
randomly assigned to either training or control groups
for the eight-week duration of the study. Controls were
instructed to continue their standard care, and were given an
opportunity to complete the training intervention after they
completed initial eight-week control period. The training
group performed, after warm-up, three sets of 5–8 rep-
etitions for the leg press, seated leg curl, and calf press
(Hammer Strength) twice weekly under direct supervision
from a Certiﬁed Strength and Conditioning Specialist. Initial
training weight was established via trial and error in the ﬁrst
and second session, so that each subject was performing at
least two sets for 8 repetitions, and the ﬁnal set between 5–
8 repetitions. Each set was a maximal eﬀo r tc a r r i e do u tt o
volitional fatigue. Subjects were instructed to lift the weight
as fast as possible with good form and to slowly return
the weight to the start position. The leg press device was
conﬁgured by the manufacturer so that each leg moved
independently, thus preventing possible masking of the
weaker leg by the more dominant leg if asymmetry existed.
Progressionwasplannedsothatwheneightrepetitionscould
be completed for all three sets, the weight was increased 5%–
10%, so that each subject was performing at least two sets for
8 repetitions, and the ﬁnal set between 5–8 repetitions.
2.3. Data Analyses. Eﬀects of the intervention were analyzed
using a 2 × 2 (group by time) repeated measures analysis
of variance. When interaction was noted, Tukey post hoc
tests were used to determine group changes from baseline.
Statistical signiﬁcance was set a priori at P ≤ .05. Eﬀect
size measures (ES) were used to show changes in terms of
standard deviation.
3. Results
Fifteen subjects completed the intervention. One individual
from the training group and two in the control group opted
not to complete the study for personal/physical reasons
unrelated to the study itself. Subject descriptive data are
shown in Table 1. No signiﬁcant diﬀerences between groups
werenotedatbaseline.Therewasasigniﬁcantgroup-by-time
interaction for relative (P = .001) and absolute (P = .001)
leg press strength. Training resulted in a signiﬁcant increase
in relative leg press (kg/kg) 1-RM (Pre = 2.1±0.6, Post =
2.7±0.7), P<. 001, ES = 0.9, Figure 1). Absolute strength
also increased signiﬁcantly in the training group (Pre =
161.0±66.9kg, Post = 199.9±67.8kg, P<. 001, ES=0.6).
In contrast, no changes were noted in relative strength for
the control group (Pre = 2.0±0.7, Post= 2.0±0.7. Data
from the control group indicate that strength appears stable
over the short term (8 weeks) in persons with PD. No
signiﬁcant interaction (P = .223) or time eﬀect (P = .07)
wasnoted forTUG(TRN:Pre=5.8± 0.50, Post=5.7±0.80,
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Figure 3:Sixminutewalkdistance(m)forTRN(Pre=537.7±88.1,
Post586.9±51.0)andCNTL(Pre=468.8±83.3,Post493.9±64.3).
No signiﬁcant interaction was noted (P = .296), but a signiﬁcant
time eﬀect was noted (P = .005).
TRN CNTL
Pre
Post
0
20
40
60
80
100
A
B
C
s
c
o
r
e
(
%
)
Figure 4: ABC scores (%) for TRN (Pre=86.2±7.5, Post
89.5±9.0) and CNTL (Pre=83.9±13.4, Post 82.8±17.5). No
signiﬁcant interaction was noted (P = .381).
ES=0.2, CNTL: Pre=7.5±1.2, Post=6.8±1.2, ES=0.6,
Figure 2). No signiﬁcant interaction was noted (P = .296),
but a signiﬁcant time eﬀect was noted (P = .005) for six
minute walk distance (Pre=503.3±85.7, Post 540.4±57.7,
ES=0.5 Figure 3). No signiﬁcant interaction (P = .381)
or time eﬀect (P = .664) was noted for ABC scores
(TRN; Pre=86.2±7.5, Post 89.5±9.0, ES=0.4, CNTL;
Pre=83.9±13.4, Post 82.8±17.5, ES=0.1, Figure 4).
4. Discussion
This is the ﬁrst investigation to date that utilized a moderate
volume (three sets of three exercises) resistance training
program consisting of multijoint exercises performed for the
lower body muscles. The only other study to use multiple4 Parkinson’s Disease
Table 1: Descriptive subject data (mean ±SD).
Variable Training Men=5, Women=3C o n t r o l M e n =4, Women=3
UPDRS Total 19.1±7.0 23.3±18.0
Hoehn and Yahr (on) Stage 2, n =7; Stage 2.5, n =1 Stage 1.5, n =2;S t a g e2 ,n =4; Stage 2.5, n =1
Age (y) 61.3±8.6 57.0±7.1
Weight (kg) 76.0±24.5 79.2±27.6
sets used a load of only 60% of a 4-repetition maximum,
and used only single-joint exercises [35]. Our results indicate
that this volume of resistance training had positive eﬀects on
muscle strength in this population, and was well tolerated.
No improvements were noted for the functional measures
in this investigation, but it should be understood that our
sample of subjects performed well at baseline for all the
functionalmeasuresandthus mayhave hadlimited potential
for gains in those measures. Several studies have shown
increases in function with strength training in neurologically
normal older adults [36, 37], and in persons with PD [20,
24]. It may be found that greater gains in strength are needed
for improvement in functional measures
4.1. Leg Strength. The percent increase in our strength
measures (relative 29%, absolute, 24%, P = .001) is
somewhat greater than the percent increase noted in most
of other existing investigations. Studies have shown 18%
improvement in unilateral knee extension torque [35], as
well as 18% [20] and 28% [24] gain in unilateral isometric
knee extension strength of the more aﬀected limb. Hass et
al. [21] demonstrated increases in knee extension strength
of 16% and 18% in the control and creatine-supplemented
groups of their study. However, Hirsch et al. [22] showed
44% increase in four-repetition knee extension strength,
but this task was not a maximal test. The four-repetition
test is unique to that study and is somewhat absent as
a performance test in strength training literature. Our
maximumstrengthmeasure,presentedinrelationtotheload
mostoftenencounteredinADL(bodymass),maybeabetter
indicator of overall functional ability [38] than non-adjusted
strength, and has been shown to correlate with TUG [14].
It may be important in future investigations to adjust lower-
body strength measures to lower-body muscle mass in order
to have a more precise estimation of muscle function.
Most researches related to resistance training in PD have
utilized very low-volume interventions [21–23]. Moreover,
the majority of these studies have employed exercises that
target a single-joint [21, 22, 35]. Some have used novel inter-
ventions such as eccentric loading [20, 24] or the addition of
nutritional supplements known to augment strength gains
in neurologically normal adults [21]. Additionally, there has
been wide disparity in the mode of strength assessment, and
in many times the testing mode is not speciﬁc to the training
mode. Such discrepancies may mask the training eﬀect
[39]. Strength testing modes include isokinetic (constant
velocity) [35], isoinertial (constant load) [23], and isometric
performance [20, 24], most often of a single joint.
Although comparing the eﬀects of a moderate exercise
volume without a direct comparison to lower-volume of
weight training is problematic, our results do indicate that
a three-set volume is as least are eﬀective in increasing
strength, and possibly more based on extant studies. In
addition, our strength measure is limited by the weaker leg,
as the arms of the leg press device move independently,
and only repetitions where both legs were extended were
used for analysis. As such, comparison to the data of Dibble
et al. [20, 24] where limbs were measured independently
seems reasonable. However, their strength measure was an
isometriccontractionandsinglejointinnature,comparedto
thebilateral,dynamic,multijointactionutilizedinourstudy.
4.2. Functional Mobility. The fact that leg strength increases
did not parallel changes in functional mobility in this inves-
tigation was unexpected, but may suggest that the strength
training adaptations may not carry over to mobility tasks in
the short term. It is likely that the baseline characteristics
of our study population also contributed to this ﬁnding. In
particular, our subjects, mean TUG (6.7s) was considerably
faster than normative data for 60–69-year-old individuals
(8.1s) [40]. Other investigations have shown signiﬁcant
performance increases in such measures as 10-minute walk
velocity and TUG [20], as well as six-minute walk and stair
descent time [24], but the participants in these investigations
were slightly more aﬀected based on Hoehn and Yahr scores
(2.5 compared to ∼2.0 in our study). Considering the
ﬁndings of these studies, and since correlations have been
found between strength and TUG [14], and with TUG and
fall risk [41], further research on the eﬀect of strength
training on functional mobility tests such as timed walking
is warranted.
The signiﬁcant time eﬀect for the 6MWT suggests a
learning eﬀect [42] that was unexpected by the research
team. It is possible that a long testing period caused the
subjects to underestimate their ability for the test during
the ﬁrst trial, leading to an increase during the second trial.
Perhaps a practice walk should be performed so that the
subjects can gauge their abilities and would be able to put
forth the appropriate eﬀort for the testing sessions. Timed
walk distance has been shown to improve after strength
training in previous studies [20, 43], and its association with
other measures of balance (ABC Scores [41], Berg Balance
Scale[44])warrantsfurtherinvestigation.Oursubjectsagain
scored rather well on this measure (baseline mean 502m)
compared to extant data of persons with PD (392m) [44].
4.3.ABC. SincethesubjectsscoredwellintheABCquestion-
naire preintervention, it is not surprising that no interaction
was noted. Ours is the ﬁrst weight training intervention toParkinson’s Disease 5
use such a questionnaire, and it is the author’s opinion that
such subjective measures of intervention eﬀectivenessshould
be applied to future research. Another work has shown
that ABC scores can predict 17.1% of the variance in the
6MWT distance [45], suggesting that this is an important
measure for persons with PD. Addition of the PDQ-39 [46],
Fatigue Severity scale [47] and possibly other scales may be
useful in evaluating the subjective eﬀectiveness and eﬃcacy
of resistance training interventions in the future.
Future studies of resistance training should include sub-
jects with more advanced disease. Additionally, to determine
the interaction of resistance training with the progression
of PD, interventions should be carried out over a longer
duration. Investigation on the mechanism of increased force
production including muscle hypertrophy and nervous sys-
temadaptationiswarranted.Furthermore,workisneededto
optimize training variables such as volume, load, mode, rest
periods, and repetition number. The ultimate eﬀectiveness
of these interventions should be determined via the eﬀects
on PD symptoms and those activities of daily living most
aﬀectedbyPD.Thisstudydemonstratedsigniﬁcantincreases
in multijoint isoinertial strength with a moderate volume
weight training program, and this volume of exercise was
well tolerated in persons with PD.
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